Results 31 to 40 of about 16,480 (226)

MTD–CoMSIA modelling of HMG-CoA reductase inhibitors [PDF]

open access: yesJournal of the Serbian Chemical Society, 2011
The 3D quantitative structure–activity relationship for a series of hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors based on the pyrrolylethyl-tetrahydropyranone scaffold was examined using the Minimal Topological Difference (MTD) method and ...
DANIEL M. DUDA-SEIMAN   +6 more
doaj  

Effects of statin use on serum creatinine phosphokinase levels in normal thyroid function [PDF]

open access: yesThe Korean Journal of Internal Medicine
Background/Aims Statins are common lipid-lowering agents used in dyslipidemia. However, they increase serum creatinine phosphokinase (CPK) levels. Currently, there are no studies on the effect of thyroid-stimulating hormone (TSH) levels on CPK levels ...
Jeonghoon Ha   +7 more
doaj   +1 more source

Statin therapy in critical illness : an international survey of intensive care physicians' opinions, attitudes and practice [PDF]

open access: yes, 2012
Background Pleotropic effects of statins on inflammation are hypothesised to attenuate the severity of and possibly prevent the occurrence of the host inflammatory response to pathogen and infection-related acute organ failure.
Di Gangi, Stefania   +6 more
core   +1 more source

Total hydroxymethylglutaryl CoA reductase activity in the small intestine and liver of insulin-deficient rats.

open access: yesJournal of Lipid Research, 1982
We examined the effect of streptozotocin-induced diabetes on the rate-limiting enzyme in cholesterol synthesis, 3-hydroxy-3-methylglutaryl CoA reductase (EC 1.1.1.34), in liver and small intestine of rats.
N L Young, C D Saudek, S A Crawford
doaj   +1 more source

Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trialResearch in context

open access: yesEClinicalMedicine, 2023
Summary: Background: Moderate-intensity statin role with ezetimibe combination therapy following percutaneous coronary intervention (PCI) has not been thoroughly investigated, particularly compared to high-intensity statin monotherapy.
Jong-Il Park   +53 more
doaj   +1 more source

From flavors and pharmaceuticals to advanced biofuels: Production of isoprenoids in Saccharomyces cerevisiae [PDF]

open access: yes, 2013
Isoprenoids denote the largest group of chemicals in the plant kingdom and are employed for a wide range of applications in the food and pharmaceutical industry.
Ajikumar   +70 more
core   +2 more sources

NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplements

open access: yesChinese Medicine, 2012
Background Red yeast rice (i.e., rice fermented with Monascus spp.), as a food supplement, is claimed to be blood cholesterol-lowering. The red yeast rice constituent monacolin K, also known as lovastatin, is an inhibitor of the hydroxymethylglutaryl-CoA
Lachenmeier Dirk W   +7 more
doaj   +1 more source

Statin-associated necrotizing myopathy: a rare etiology

open access: yesRevista Portuguesa de Medicina Geral e Familiar, 2020
Introduction: Necrotizing autoimmune myopathy is a rare entity characterized by proximal muscle weakness, elevated creatine kinase levels, potential autoantibody presence, and myofiber necrosis with reduced or absent inflammation.
Catarina Ferreira Moita   +4 more
doaj   +1 more source

Advances in Pathway Engineering for Natural Product Biosynthesis [PDF]

open access: yes, 2015
Biocatalysts provide an efficient, inexpensive and environmentally friendly alternative to traditional organic synthesis, especially for compounds with complex stereochemistries.
Aharoni   +127 more
core   +1 more source

Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muscle cells [PDF]

open access: yes, 2015
BACKGROUND: Vascular calcification is an independent risk factor for cardiovascular disease. Diabetes mellitus increases the incidence of vascular calcification; however, detailed molecular mechanisms of vascular calcification in diabetes mellitus remain
Ken-ichi Hirata   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy